Nishan M DeSilva Insider Trading
Get free email notifications about insider trading for Nishan M DeSilva.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nishan M DeSilva. Nishan M DeSilva is a VP, Corporate Development in LIGAND PHARMACEUTICALS INC ($LGND).
Address: 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA 92037 CA
Companies in which Nishan M DeSilva is an Insider
LIGAND PHARMACEUTICALS INC
Trading Symbol: LGNDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nishan M DeSilva: VP, Corporate Development
Holdings: 22,282 shares
Current Value: $2,402,891
Latest Transaction: Feb 11 2015
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Nishan M DeSilva
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 56.26 | 20,873 | 1,174,315 | 20,873 | |
Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Grant | A | 0.00 | 5,923 | 0 | 22,282 | 16.4 K to 22.3 K (+36.21 %) |
Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Sell | S | 56.34 | 2,300 | 129,582 | 16,359 | 18.7 K to 16.4 K (-12.33 %) |
Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 74.42 | 5,000 | 372,100 | 45,000 | |
Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 74.42 | 5,000 | 372,100 | 40,000 | |
Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 74.42 | 35,000 | 2,604,700 | 35,000 | |
Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Grant | A | 0.00 | 3,000 | 0 | 18,659 | 15.7 K to 18.7 K (+19.16 %) |